Following up on the whole discipline angle from the last post, it definitely seems like more is going to happen before there is either any legal action or baseball disciplinary action in the A-Rod case. I mean, last I checked we don’t prosecute people based on newspaper articles alone.
But what that next step is will be extremely interesting. Because it will tell us whether Major League Baseball and the DEA is more interested in drug users or drug dealers.
Back in the Mitchell Report days, MLB, George Mitchell and federal agents went to the drug dealers first and gave them various degrees of immunity. Why? Because no one cared about drug dealers. The Mitchell Report, as I wrote at length back in the day, was a public relations exercise and everyone involved wanted to get the names of PED-using players out in the open. The league wanted to look like it was taking action, George Mitchell wanted prestige and billable hours for his law firm and the feds wanted some big, celebrity heads on pikes. This, by the way, is a lot of the reason why the lowest hanging fruit was picked back then and guys like A-Rod and Biogenesis went unmentioned.
But what now? Once again we have MLB and the DEA pursuing PEDs. Based on the Miami New Times report, the next obvious move for law enforcement is to either get players like A-Rod, Nelson Cruz, Bartolo Colon, Gio Gonzalez and others in a room to talk about the clinic’s possibly illegal prescriptions or else to get the clinic’s operators in to talk about the users. That’s how the next phase of this has to go.
Will the DEA decide to pursue distributors or end users? Will MLB seek out the quickest means to get “just cause” suspension evidence on the players, or will it attempt to learn everything it can about what may very well be the biggest pipeline of drugs into its sport?
The choices that are made about all of this in the coming days will tell us a lot about the league’s and the feds’ priorities.
Mets’ left-hander Steven Matz will miss his Grapefruit League appearance on Monday after experiencing soreness in his left elbow, according to a report by Mike Puma of the New York Post. Matz reportedly first felt discomfort in his elbow on Wednesday after pitching four innings against the Marlins, but a medical evaluation revealed no structural damage.
Still, it’s unsettling news for the 25-year-old, who is coming off of an injury-riddled 2016 season. Matz pitched to a 3.40 ERA, 2.1 BB/9 and 8.8 SO/9 during his sophomore campaign with the Mets, but his success was hampered by a bevy of shoulder and elbow issues that culminated in season-ending surgery to remove bone spurs from his left elbow.
Comments from Mets’ GM Sandy Alderson indicated that while the club doesn’t believe anything is significantly wrong with Matz’s elbow this time around, the setback could have an impact on his chances of cracking the Opening Day roster. Until he’s cleared to return to the mound, the club is expected to take a longer look at rotation candidates Robert Gsellman, Zack Wheeler and Seth Lugo.
Dodgers’ left fielder Andrew Toles crushed his first spring training home run on Saturday afternoon. With the bases loaded and a two-run deficit hanging over their heads in the fourth inning, Toles stepped up to the plate against Oakland right-hander Jesse Hahn and unloaded a grand slam on the second pitch he saw.
Third baseman Justin Turner was quick to follow up with a solo jack of his own, bringing the score to a comfortable 7-4 lead by the end of the fourth. Another three-run outburst in the fifth and an eighth-inning RBI single by Austin Barnes raised the final score to 11-6… which, coincidentally, was the same score the Reds used to defeat the Athletics’ second split-squad lineup on Saturday (albeit with a few more RBI walks than grand slams).
Toles, 24, is approaching his sophomore season with the Dodgers in 2017. He slashed .314/.365/.505 with three home runs and an .870 OPS in his first major league season in 2016 and is expected to platoon with the right-handed Franklin Gutierrez in left field this year.